PURPOSE: To evaluate the reproducibility of neural activations induced by an anticipatory anxiety provocation challenge in healthy volunteers. MATERIALS AND METHODS: Fourteen healthy male volunteers participated in two separate functional MRI (fMRI) sessions in which they underwent a paradigm based on anticipation of aversive transcutaneous electrical nerve stimulations. This paradigm consisted of alternating presentation of red circles associated with the likelihood that aversive stimuli may be given and blue circles during which the subjects knew that no shock could be given. Anxiety state was compared before the fMRI sessions and during the threat periods using clinical scales (Hamilton, STAI-Y1), the Bond and Lader Visual Analogue Scale, and self-rating scales of apprehension and stimulus aversivity. RESULTS: The selected paradigm induced anticipatory anxiety of moderate intensity as suggested by clinical scales and apprehension rating, without any habituation to the somatosensory stimulus across sessions. Compared to rest periods, threat of the aversive stimulus induced clear brain activation in anticipatory anxiety-related areas: frontal/prefrontal cortex, insula, lentiform nucleus, temporal pole, and cingulate cortex. Anxiety symptoms and cerebral activity were reproducible across sessions. CONCLUSION: The fMRI paradigm and its assessment method include all criteria to speed up the evaluation and the development of new anxiolytics.
PURPOSE: To evaluate the reproducibility of neural activations induced by an anticipatory anxiety provocation challenge in healthy volunteers. MATERIALS AND METHODS: Fourteen healthy male volunteers participated in two separate functional MRI (fMRI) sessions in which they underwent a paradigm based on anticipation of aversive transcutaneous electrical nerve stimulations. This paradigm consisted of alternating presentation of red circles associated with the likelihood that aversive stimuli may be given and blue circles during which the subjects knew that no shock could be given. Anxiety state was compared before the fMRI sessions and during the threat periods using clinical scales (Hamilton, STAI-Y1), the Bond and Lader Visual Analogue Scale, and self-rating scales of apprehension and stimulus aversivity. RESULTS: The selected paradigm induced anticipatory anxiety of moderate intensity as suggested by clinical scales and apprehension rating, without any habituation to the somatosensory stimulus across sessions. Compared to rest periods, threat of the aversive stimulus induced clear brain activation in anticipatory anxiety-related areas: frontal/prefrontal cortex, insula, lentiform nucleus, temporal pole, and cingulate cortex. Anxiety symptoms and cerebral activity were reproducible across sessions. CONCLUSION: The fMRI paradigm and its assessment method include all criteria to speed up the evaluation and the development of new anxiolytics.
Authors: Emily M Drabant; Janice R Kuo; Wiveka Ramel; Jens Blechert; Michael D Edge; Jeff R Cooper; Philippe R Goldin; Ahmad R Hariri; James J Gross Journal: Neuroimage Date: 2010-11-18 Impact factor: 6.556
Authors: Eva-Maria Seidel; Daniela M Pfabigan; Andreas Hahn; Ronald Sladky; Arvina Grahl; Katharina Paul; Christoph Kraus; Martin Küblböck; Georg S Kranz; Allan Hummer; Rupert Lanzenberger; Christian Windischberger; Claus Lamm Journal: Hum Brain Mapp Date: 2014-10-16 Impact factor: 5.038
Authors: Joseph P Schacht; Raymond F Anton; Patrick K Randall; Xingbao Li; Scott Henderson; Hugh Myrick Journal: Neuroimage Date: 2011-02-18 Impact factor: 6.556
Authors: J-Y Hong; B Naliboff; J S Labus; A Gupta; L A Kilpatrick; C Ashe-McNalley; J Stains; N Heendeniya; S R Smith; K Tillisch; E A Mayer Journal: Neurogastroenterol Motil Date: 2015-11-03 Impact factor: 3.598
Authors: Steven E Bruce; Katherine R Buchholz; Wilson J Brown; Laura Yan; Anthony Durbin; Yvette I Sheline Journal: Neuroimage Clin Date: 2012-11-13 Impact factor: 4.881
Authors: S Haller; G Cunningham; A Laedermann; J Hofmeister; D Van De Ville; K-O Lovblad; P Hoffmeyer Journal: AJNR Am J Neuroradiol Date: 2013-10-03 Impact factor: 3.825